Last reviewed · How we verify
NCT02150889: TrainMeUpMN
Training Effects on Fuel Metabolism
NA trial testing Running Program in Healthy Subjects in 64 participants. Participants enrolled and being followed up; not accepting new ones.
30 December 2018
Quick facts
| Lead sponsor | University of Minnesota |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 1 July 2014 |
| Primary completion | 30 December 2018 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Running Program
- Yoga Program
Conditions studied
- Healthy Subjects — all drugs for Healthy Subjects →
- Lean Trained Subjects — all drugs for Lean Trained Subjects →
- Overweight and Obesity — all drugs for Overweight and Obesity →
Sponsor
University of Minnesota
Who can join
Adults 18 to 40, any sex, with Healthy Subjects or Lean Trained Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators are interested in how skeletal muscle processes fat and how this may affect insulin resistance. This is an important question since insulin resistance predates and predicts type 2 diabetes. The investigators are especially interested in learning about the effects of weight and training on insulin resistance. The investigators will study people before and after supervised aerobic or yoga training to identify differences in resting fat and sugar metabolism which may lead to differences in insulin resistance. The investigators will test these differences using stable isotopes, and the use of these stable isotopes is experimental. Overweight/Obese Group: Eight visits will be required at the University of Minnesota Clinical Research Unit. Four visits will be done before training (screen and 3 pre-training visits), 1 visit during the training, and 3 post-training visits will be done. In between, the training will take about 16 weeks and will be a supervised treadmill program. Lean/Trained Group: Four visits will be required at the University of Minnesota Clinical Research Unit (screen and 3 study visits).
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Acute aerobic exercise reveals that FAHFAs distinguish the metabolomes of overweight and normal-weight runners.
Nelson AB, Chow LS, Stagg DB, Gillingham JR, et al · · 2022 · cited 19× · PMID 35192550 · DOI 10.1172/jci.insight.158037 -
DXA-Determined Regional Adiposity Relates to Insulin Resistance in a Young Adult Population with Overweight andObesity.
Bantle AE, Bosch TA, Dengel DR, Wang Q, et al · · 2019 · cited 10× · PMID 30064815 · DOI 10.1016/j.jocd.2018.06.001 -
56<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : 21-25 September 2020.
· 2020 · cited 9× · PMID 32840677 · DOI 10.1007/s00125-020-05221-5 -
V<sub>E</sub>/VCO<sub>2</sub> slope in lean and overweight women and its relationship to lean leg mass.
Keller-Ross ML, Chantigian DP, Evanoff N, Bantle AE, et al · · 2018 · cited 5× · PMID 30426069 · DOI 10.1016/j.ijcha.2018.10.009 -
The impact of high BMI on acute changes in body composition following 90 minutes of running.
Brayton SH, Bosch TA, Bantle AE, Hodges JS, et al · · 2018 · PMID 31380465 · DOI 10.1080/2331205x.2018.1502960
Verify or expand the search:
- PubMed search for NCT02150889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Subjects
Currently open trials in the same condition.
- NCT07222020 — Phase 1 Study of Intravaginal KB15A · Phase 1 · recruiting
- NCT07350538 — The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL · NA · active not recruiting
- NCT07304791 — This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and P · Phase 1 · recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07331389 — A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin · Phase 1 · recruiting
Other University of Minnesota trials
Trials by the same sponsor.
- NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
- NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
- NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02150889 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02150889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing